Torres Lab Receives $1.8M NIH Renewal to Continue Parkinson’s Disease Research
The National Institutes of Health has awarded a competitive renewal of R01 NS112357 to the Torres Laboratory, providing continued support through 2027 for investigation into gut microbiota modulation as a neuroprotective strategy in Parkinson's disease.
The National Institutes of Health has awarded a competitive renewal of R01 NS112357 to the Torres Laboratory, providing continued support through 2027 for investigation into gut microbiota modulation as a neuroprotective strategy in Parkinson’s disease.